Brief: scPharmaceuticals Inc Reports Third Quarter 2021 Financial Results And Provides Business Update

Scpharmaceuticals

09/11/2021 12:40

Nov 9 (Reuters) - scPharmaceuticals Inc  SCPH.O :
    * SCPHARMACEUTICALS INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * SCPHARMACEUTICALS - MODESTLY REVISING TIMING OF FUROSCIX
NDA
RESUBMISSION TO Q1 2022, REFLECTING IMPACT THAT COVID-19 HAS HAD
ON THIRD-PARTY PARTNERS
    * SCPHARMACEUTICALS INC - SEES A NET LOSS FOR 2021 TO BE IN
RANGE
OF $29.0 MILLION TO $31.0 MILLION FOR FISCAL YEAR
    * SCPHARMACEUTICALS INC - SEES ITS CASH, EQUIVALENTS,
SUFFICIENT
TO FUND OPERATIONS INTO 2023
    * SCPHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.24

Source text for Eikon:  ID:nGNXbrzvJ3 
Further company coverage:  SCPH.O